You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This first book specifically dedicated to ectoparasite drug discovery is unique in providing insights from the veterinary as well as the medical perspective, covering research from both industry and academia while paving the way for new synergies between the two research communities. Edited by a team combining 80 years of experience in academic research and industrial antiparasitic drug discovery, this volume of Drug Discovery in Infectious Diseases summarizes current knowledge in this rapidly expanding field. Comprehensive yet concise, this ready reference blends solid background information on ectoparasite biology with the very latest methods in ectoparasite drug discovery. Three major parts cover current ectoparasite control strategies and the threat of drug resistance, screening and drug evaluation, and the new isoxazoline class of ectoparasiticides. The future potential of mechanism-based approaches for repellents and parasiticides is thoroughly discussed, as are strategies for vaccines against ectoparasites, making the book ideal for parasitologists in academia as well as researchers working in the pharmaceutical industry.
Dieser Werk behandelt umfassend und aktuell Stoffwechselveränderungen beim Menschen, die mit Wirt-Erreger-Beziehungen in Zusammenhang stehen. Teil 1 beschreibt die Anpassung pathogener Mikroben an Stoffwechselvorgänge. Teil 2 zeigt Wege für die Entwicklung neuartiger Antibiotika.
At Frontiers our mission is to make science open – so that scientists can collaborate better and innovate faster to deliver the solutions that enable healthy lives on a healthy planet. We do this through our community driven Open Access journals. As researchers across the globe work on tackling the challenges facing immunology in the field of Microbial Immunology, they publish their success stories. However, it is equally important for researchers to discuss the challenges they face on the road to success, as most innovation begins with failure. Our Open Access publication allows researchers to discover the areas for development in the field and to provide a focus for future research. This Research Topic will highlight the importance of learning from one another in the scientific community and continue to highlight areas for progress. This Research Topic welcomes Reviews, Mini-reviews, Original Research, and Perspectives that highlight the field of Microbial Immunology from the following perspectives: - Recent success stories with a focus on the challenges faced and overcame. - Current challenges in the field and emerging research to innovate.
Written and edited by experts in the field, this book brings together the current state of the art in phenotypic and rational, target-based approaches to drug discovery against pathogenic protozoa. The chapters focus particularly on virtual compounds and high throughput screening, natural products, computer-assisted drug design, structure-based drug design, mechanism of action identification, and pathway modelling. Furthermore, state-of the art "omics" technologies are described and currently studied enzymatic drug targets are discussed. Mathematical, systems biology-based approaches are introduced as new methodologies for dissecting complex aspects of pathogen survival mechanisms and for target identification. In addition, recently developed anti-parasitic agents targeting particular pathways, which serve as lead compounds for further drug development, are presented.
None
This third volume in the successful 'Drug Discovery in Infectious Diseases' series is the first to deal with drug discovery in helminthic infections in human and animals. The result is a broad overview of different drug target evaluation methods, including specific examples of successful drug development against helminthes, and with a whole section devoted to vaccine development. With its well-balanced mix of high-profile contributors from academia and industry, this handbook and reference will appeal to a wide audience, including parasitologists, pharmaceutical industry, epidemiologists, and veterinary scientists.